1. Home
  2. CTXR vs UCAR Comparison

CTXR vs UCAR Comparison

Compare CTXR & UCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • UCAR
  • Stock Information
  • Founded
  • CTXR 2007
  • UCAR 2013
  • Country
  • CTXR United States
  • UCAR China
  • Employees
  • CTXR N/A
  • UCAR N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • UCAR Retail-Auto Dealers and Gas Stations
  • Sector
  • CTXR Health Care
  • UCAR Consumer Discretionary
  • Exchange
  • CTXR Nasdaq
  • UCAR Nasdaq
  • Market Cap
  • CTXR 14.6M
  • UCAR 13.3M
  • IPO Year
  • CTXR N/A
  • UCAR 2023
  • Fundamental
  • Price
  • CTXR $1.53
  • UCAR $3.86
  • Analyst Decision
  • CTXR Strong Buy
  • UCAR
  • Analyst Count
  • CTXR 3
  • UCAR 0
  • Target Price
  • CTXR $53.00
  • UCAR N/A
  • AVG Volume (30 Days)
  • CTXR 6.7M
  • UCAR 52.7K
  • Earning Date
  • CTXR 08-11-2025
  • UCAR 07-07-2025
  • Dividend Yield
  • CTXR N/A
  • UCAR N/A
  • EPS Growth
  • CTXR N/A
  • UCAR N/A
  • EPS
  • CTXR N/A
  • UCAR N/A
  • Revenue
  • CTXR N/A
  • UCAR $6,067,871.00
  • Revenue This Year
  • CTXR N/A
  • UCAR N/A
  • Revenue Next Year
  • CTXR N/A
  • UCAR N/A
  • P/E Ratio
  • CTXR N/A
  • UCAR N/A
  • Revenue Growth
  • CTXR N/A
  • UCAR 124.09
  • 52 Week Low
  • CTXR $0.65
  • UCAR $2.30
  • 52 Week High
  • CTXR $26.25
  • UCAR $9.43
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 68.44
  • UCAR 58.97
  • Support Level
  • CTXR $0.76
  • UCAR $3.53
  • Resistance Level
  • CTXR $1.45
  • UCAR $4.32
  • Average True Range (ATR)
  • CTXR 0.31
  • UCAR 0.39
  • MACD
  • CTXR 0.06
  • UCAR 0.04
  • Stochastic Oscillator
  • CTXR 47.63
  • UCAR 58.17

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

Share on Social Networks: